"World's Most Complete Market Research Reports Repository"

Global Imatinib Drug Market Insights, Forecast to 2025

This report studies the global market size of Imatinib Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Imatinib Drug in these regions.
This research report categorizes the global Imatinib Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
In 2017, the global Imatinib Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Imatinib Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Imatinib Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Imatinib Drug include
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.

Market Size Split by Type
Tablets
Capsules
Market Size Split by Application
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Imatinib Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Imatinib Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Imatinib Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Imatinib Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Imatinib Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Imatinib Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Imatinib Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Imatinib Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Imatinib Drug Market Size Growth Rate by Type
1.4.2 Tablets
1.4.3 Capsules
1.5 Market by Application
1.5.1 Global Imatinib Drug Market Size Growth Rate by Application
1.5.2 Chronic myelogenous leukemia
1.5.3 Gastrointestinal stromal tumors
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Imatinib Drug Market Size
2.1.1 Global Imatinib Drug Revenue 2016-2025
2.1.2 Global Imatinib Drug Sales 2016-2025
2.2 Imatinib Drug Growth Rate by Regions
2.2.1 Global Imatinib Drug Sales by Regions
2.2.2 Global Imatinib Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Imatinib Drug Sales by Manufacturers
3.1.1 Imatinib Drug Sales by Manufacturers
3.1.2 Imatinib Drug Sales Market Share by Manufacturers
3.1.3 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI)
3.2 Imatinib Drug Revenue by Manufacturers
3.2.1 Imatinib Drug Revenue by Manufacturers (2016-2018)
3.2.2 Imatinib Drug Revenue Share by Manufacturers (2016-2018)
3.3 Imatinib Drug Price by Manufacturers
3.4 Imatinib Drug Manufacturing Base Distribution, Product Types
3.4.1 Imatinib Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Imatinib Drug Product Category
3.4.3 Date of International Manufacturers Enter into Imatinib Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Imatinib Drug Sales by Type
4.2 Global Imatinib Drug Revenue by Type
4.3 Imatinib Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Imatinib Drug Breakdown Data by Application

6 North America
6.1 North America Imatinib Drug by Countries
6.1.1 North America Imatinib Drug Sales by Countries
6.1.2 North America Imatinib Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Imatinib Drug by Type
6.3 North America Imatinib Drug by Application
6.4 North America Imatinib Drug by Company

7 Europe
7.1 Europe Imatinib Drug by Countries
7.1.1 Europe Imatinib Drug Sales by Countries
7.1.2 Europe Imatinib Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Imatinib Drug by Type
7.3 Europe Imatinib Drug by Application
7.4 Europe Imatinib Drug by Company

8 Asia Pacific
8.1 Asia Pacific Imatinib Drug by Countries
8.1.1 Asia Pacific Imatinib Drug Sales by Countries
8.1.2 Asia Pacific Imatinib Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Imatinib Drug by Type
8.3 Asia Pacific Imatinib Drug by Application
8.4 Asia Pacific Imatinib Drug by Company

9 Central & South America
9.1 Central & South America Imatinib Drug by Countries
9.1.1 Central & South America Imatinib Drug Sales by Countries
9.1.2 Central & South America Imatinib Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Imatinib Drug by Type
9.3 Central & South America Imatinib Drug by Application
9.4 Central & South America Imatinib Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drug by Countries
10.1.1 Middle East and Africa Imatinib Drug Sales by Countries
10.1.2 Middle East and Africa Imatinib Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Imatinib Drug by Type
10.3 Middle East and Africa Imatinib Drug by Application
10.4 Middle East and Africa Imatinib Drug by Company

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.1.4 Imatinib Drug Product Description
11.1.5 Recent Development
11.2 Glenmark Pharmaceuticals Ltd.
11.2.1 Glenmark Pharmaceuticals Ltd. Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.2.4 Imatinib Drug Product Description
11.2.5 Recent Development
11.3 Sun Pharmaceuticals
11.3.1 Sun Pharmaceuticals Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.3.4 Imatinib Drug Product Description
11.3.5 Recent Development
11.4 Actavis Generics
11.4.1 Actavis Generics Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.4.4 Imatinib Drug Product Description
11.4.5 Recent Development
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.5.4 Imatinib Drug Product Description
11.5.5 Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.6.4 Imatinib Drug Product Description
11.6.5 Recent Development
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.7.4 Imatinib Drug Product Description
11.7.5 Recent Development
11.8 Cipla Inc.
11.8.1 Cipla Inc. Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.8.4 Imatinib Drug Product Description
11.8.5 Recent Development
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.9.4 Imatinib Drug Product Description
11.9.5 Recent Development
11.10 Mylan Pharms Inc.
11.10.1 Mylan Pharms Inc. Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Imatinib Drug
11.10.4 Imatinib Drug Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Imatinib Drug Raw Material
13.1.2 Imatinib Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Imatinib Drug
Figure Global Imatinib Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Imatinib Drug Production Market Share by Types (Product Category) in 2017
Figure Tablets Product Picture
Table Major Manufacturers of Tablets
Figure Capsules Product Picture
Table Major Manufacturers of Capsules
Table Global Imatinib Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Chronic myelogenous leukemia
Figure Gastrointestinal stromal tumors
Figure Others
Figure Imatinib Drug Report Years Considered
Figure Global Imatinib Drug Market Size 2016-2025 (Million US$)
Figure Global Imatinib Drug Sales 2016-2025 (K Units)
Table Global Imatinib Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Imatinib Drug Sales by Regions 2016-2025 (K Units)
Table Global Imatinib Drug Sales Market Share by Regions 2016-2025
Figure Global Imatinib Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Imatinib Drug Sales Market Share by Regions
Table Global Imatinib Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Imatinib Drug Revenue Market Share by Regions 2016-2025
Figure Global Imatinib Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Imatinib Drug Revenue Market Share by Regions
Table Global Imatinib Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Imatinib Drug Sales Share by Manufacturers (2016-2018)
Figure Global Imatinib Drug Sales Share by Manufacturers in 2017
Table Imatinib Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Imatinib Drug Revenue Share by Manufacturers (2016-2018)
Figure Imatinib Drug Value Share by Manufacturers in 2017
Table Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Imatinib Drug Price (2016-2018) (USD/Unit)
Table Imatinib Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Imatinib Drug Product Category
Table Date of International Manufacturers Enter into Imatinib Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Imatinib Drug Sales by Type (2016-2025) (K Units)
Table Global Imatinib Drug Sales Share by Type (2016-2025)
Figure Global Imatinib Drug Sales Market Share by Type (2016-2025)
Figure Global Imatinib Drug Sales Market Share by Type in 2017
Table Global Imatinib Drug Revenue by Type (2016-2025) (Million US$)
Table Global Imatinib Drug Revenue Share by Type (2016-2025)
Figure Global Imatinib Drug Revenue Market Share by Type (2016-2025)
Figure Global Imatinib Drug Revenue Market Share by Type in 2017
Table Imatinib Drug Price by Type 2013-2018 (USD/Unit)
Table Global Imatinib Drug Sales by Application (2016-2025) (K Units)
Table Global Imatinib Drug Sales Share by Application (2016-2025)
Figure Global Sales Imatinib Drug Market Share by Application (2016-2025)
Figure Global Sales Imatinib Drug Market Share by Application (2016-2025)
Figure North America Imatinib Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Imatinib Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Imatinib Drug Sales by Countries (2016-2025) (K Units)
Table North America Imatinib Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Imatinib Drug Sales Market Share by Countries
Table North America Imatinib Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Imatinib Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Imatinib Drug Revenue Market Share by Countries
Figure United States Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Imatinib Drug Sales by Type (2016-2025) (K Units)
Table North America Imatinib Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Imatinib Drug Market Share by Type
Table North America Imatinib Drug Sales by Application (2016-2025) (K Units)
Table North America Imatinib Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Imatinib Drug Market Share by Application
Table North America Imatinib Drug Sales by Company (2016-2018) (K Units)
Table North America Imatinib Drug Sales Market Share by Company (2016-2018)
Figure North America Imatinib Drug Sales Market Share by Company in 2017
Figure Europe Imatinib Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Imatinib Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Imatinib Drug Sales by Countries (2016-2025) (K Units)
Table Europe Imatinib Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Imatinib Drug Sales Market Share by Countries
Table Europe Imatinib Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Imatinib Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Imatinib Drug Revenue Market Share by Countries
Figure Germany Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Imatinib Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Imatinib Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Imatinib Drug Sales by Type (2016-2025) (K Units)
Table Europe Imatinib Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Imatinib Drug Market Share by Type
Table Europe Imatinib Drug Sales by Application (2016-2025) (K Units)
Table Europe Imatinib Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Imatinib Drug Market Share by Application
Table Europe Imatinib Drug Sales by Company (2016-2018) (K Units)
Table Europe Imatinib Drug Sales Market Share by Company (2016-2018)
Figure Europe Imatinib Drug Sales Market Share by Company in 2017
Figure Asia Pacific Imatinib Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Imatinib Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Imatinib Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Imatinib Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Imatinib Drug Sales Market Share by Countries
Table Asia Pacific Imatinib Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Imatinib Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Imatinib Drug Revenue Market Share by Countries
Figure China Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Imatinib Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Imatinib Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Imatinib Drug Market Share by Type
Table Asia Pacific Imatinib Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Imatinib Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Imatinib Drug Market Share by Application
Table Asia Pacific Imatinib Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Imatinib Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Imatinib Drug Sales Market Share by Company in 2017
Figure Central & South America Imatinib Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Imatinib Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Imatinib Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Imatinib Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Imatinib Drug Sales Market Share by Countries
Table Central & South America Imatinib Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Imatinib Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Imatinib Drug Revenue Market Share by Countries
Figure Brazil Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Imatinib Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Imatinib Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Imatinib Drug Market Share by Type
Table Central & South America Imatinib Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Imatinib Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Imatinib Drug Market Share by Application
Table Central & South America Imatinib Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Imatinib Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Imatinib Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Imatinib Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Imatinib Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Imatinib Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Imatinib Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Imatinib Drug Sales Market Share by Countries
Table Middle East and Africa Imatinib Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Imatinib Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Imatinib Drug Revenue Market Share by Countries
Figure GCC Countries Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Imatinib Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Imatinib Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Imatinib Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Imatinib Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Imatinib Drug Market Share by Type
Table Middle East and Africa Imatinib Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Imatinib Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Imatinib Drug Market Share by Application
Table Middle East and Africa Imatinib Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Imatinib Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Imatinib Drug Sales Market Share by Company in 2017
Table Novartis Company Details
Table Novartis Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Glenmark Pharmaceuticals Ltd. Company Details
Table Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Glenmark Pharmaceuticals Ltd. Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sun Pharmaceuticals Recent Development
Table Actavis Generics Company Details
Table Actavis Generics Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Actavis Generics Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dr. Reddy's Laboratories Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi S.A. Recent Development
Table Cipla Inc. Company Details
Table Cipla Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cipla Inc. Recent Development
Table Apotex Inc. Company Details
Table Apotex Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Apotex Inc. Recent Development
Table Mylan Pharms Inc. Company Details
Table Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Pharms Inc. Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Imatinib Drug Value Chain
Table Typical Suppliers of Key Imatinib Drug Raw Material
Table Imatinib Drug Customers List
Table Imatinib Drug Sales Channels
Table Imatinib Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type